Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters

European Journal of Pharmacology

Volumn 349, Issue 1, 1998, Pages 129-132

  Béïque, Jean Claude ^a   Lavoie, Normand ^a   De Montigny, Claude ^a   Debonnel, Guy ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT (5 hydroxytryptaminc, 5 HT) transporter; Antidepressant; Binding; Duloxetine; Norepinephrine transporter

Indexed keywords

CIANOPRAMINE; DESIPRAMINE; DULOXETINE; FLUVOXAMINE; NISOXETINE; NORADRENALIN; SEROTONIN; SEROTONIN TRANSPORTER; VENLAFAXINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG ACTIVITY; DRUG POTENCY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BINDING, COMPETITIVE; BRAIN; CARRIER PROTEINS; CYCLOHEXANOLS; FLUOXETINE; IMIPRAMINE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEUROTRANSMITTER UPTAKE INHIBITORS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYMPORTERS;

EID: 0032524235     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00241-6     Document Type: Article

References (15)

1. Béïque J.C., De Montigny C., Blier P., Debonnel G. Blockade of 5-HT and NE reuptake by venlafaxine: in vivo electrophysiological studies in the rat. Soc. Neurosci. Abstr. 22:1996;180.
2. Blier P., De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-226.
3. Bolden-Watson C., Richelson E. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. 52:1993;1023-1029.
4. Burkard W.P. Specific binding sites in rat brain for a new and potent inhibitor of 5-hydroxytryptamine uptake: Ro-11-2465. Eur. J. Pharmacol. 61:1980;409-410.
5. 3H ]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments Neuropharmacology. 35:1996;63-70.
6. De Montigny, C., Debonnel, G., Bergeron, R., St-Andre, E., Blier, P., 1996. Venlafaxine in treatment-resistant depression: an open-label multicenter study. ACNP 34th Annual Meeting, 158.
7. Dierick M., Ravizza L., Realini R., Martin A. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 20:1996;57-71.
8. 3H ]imipramine binding site Mol. Pharmacol. 23:1983;607-613.
9. 3H ]nisoxetine binding in rat brain J. Neurochem. 64:1995;2792-2800.
10. Kasamo K., Blier P., De Montigny C. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain. J. Pharmacol. Exp. Ther. 277:1996;278-286.
11. Muth E.A., Haskins J.T., Moyer J.A., Husbands G.E., Nielsen S.T., Sigg E.B. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem. Pharmacol. 35:1986;4493-4497.
12. Nierenberg A.A., Feighner J.P., Rudolph R., Cole J.O., Sullivan J. Venlafaxine for treatment-resistant unipolar depression. J. Clin. Psychopharmacol. 14:1994;419-423.
13. Rickels K. Venlafaxine: A new potent antidepressant agent with putative fast onset of action. Biol. Psychiatry. 1:1991;345-346.
14. 3H ]Nisoxetine: a new radioligand for norepinephrine uptake sites in brain Eur. J. Pharmacol. 191:1990;239-243.
15. Wong D.T., Bymaster F.P., Mayle D.A., Reid L.R., Krushinski J.H., Robertson D.W. LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology. 8:1993;23-33.